IRWD compared with MGNX: revenue, margins and what each company keeps, and the suppliers and customers both name

IRWDIronwood Pharmaceuticals Inc

Mkt capRevenueRevenue

MGNXMacrogenics Inc

Mkt capRevenueRevenue

Compare

IRWDIronwood Pharmaceuticals Inc

MGNXMacrogenics Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

IRWDIronwood Pharmaceuticals Inc

3.54▲+1.28%

Mkt cap$578.3MRevenue$113MQ2 FY26Revenue$296MFY25

MGNXMacrogenics Inc

2.42▲+0.96%

Regular sessionSep 2 '83

Mkt cap$152.9MRevenue$33MQ2 FY26Revenue$134MFY25

Compare

Regular sessionSep 2 '83

IRWDIronwood Pharmaceuticals Inc

MGNXMacrogenics Inc

3.54▲+1.28%

Price

2.42▲+0.96%

$578.3M

Mkt cap

$152.9M

Q2 FY26$113M

Revenue

$33MQ2 FY26

FY25$296M

Revenue

$134MFY25

IRWD3.54▲+1.28%vsMGNX2.42▲+0.96%Regular sessionSep 2 '83

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

MGNX: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only IRWD 8

ABBVAbbViesupplier

AZNAstraZeneca ABcustomer

—Ferringunlistedsupplier

—Courunlistedsupplier

4 more · IRWD chain ›

Shared 0

No shared counterparties.

Only MGNX 17

GILDGilead Sciences, Inc. (Gilead)customer

INCYIncyte Corporation (Incyte)customer

EBSEmergent BioSolutions (Emergent)customer

—Byondisunlisted

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

supplier

13 more · MGNX chain ›

Price

rebased to 0%

IRWD, solidMGNX, dashed